These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20149682)

  • 1. Data-dependent neutral gain MS3: toward automated identification of the N-oxide functional group in drug metabolites.
    Habicht SC; Vinueza NR; Duan P; Fu M; Kenttämaa HI
    J Am Soc Mass Spectrom; 2010 Apr; 21(4):559-63. PubMed ID: 20149682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatography/tandem mass spectrometry utilizing ion-molecule reactions and collision-activated dissociation for the identification of N-oxide drug metabolites.
    Habicht SC; Duan P; Vinueza NR; Fu M; Kenttämaa HI
    J Pharm Biomed Anal; 2010 Mar; 51(4):805-11. PubMed ID: 19897332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid methodology for the characterization of dialkyl tertiary amine-N-oxide metabolites using structurally dependent dissociation pathways and reconstructed ion current chromatograms.
    Holman SW; Wright P; Langley GJ
    Anal Chem; 2010 Mar; 82(6):2347-54. PubMed ID: 20158225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isobaric metabolite interferences and the requirement for close examination of raw data in addition to stringent chromatographic separations in liquid chromatography/tandem mass spectrometric analysis of drugs in biological matrix.
    Yan Z; Maher N; Torres R; Cotto C; Hastings B; Dasgupta M; Hyman R; Huebert N; Caldwell GW
    Rapid Commun Mass Spectrom; 2008 Jul; 22(13):2021-8. PubMed ID: 18512848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated neutral loss and data dependent energy resolved "pseudo MS3" for the targeted identification, characterization and quantitative analysis of methionine- containing peptides.
    Froelich JM; Kaplinghat S; Reid GE
    Eur J Mass Spectrom (Chichester); 2008; 14(4):219-29. PubMed ID: 18756020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid screening and confirmation of drugs and toxic compounds in biological specimens using liquid chromatography/ion trap tandem mass spectrometry and automated library search.
    Liu HC; Liu RH; Lin DL; Ho HO
    Rapid Commun Mass Spectrom; 2010 Jan; 24(1):75-84. PubMed ID: 19957291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultra-performance liquid chromatography/tandem mass spectrometric quantification of structurally diverse drug mixtures using an ESI-APCI multimode ionization source.
    Yu K; Di L; Kerns E; Li SQ; Alden P; Plumb RS
    Rapid Commun Mass Spectrom; 2007; 21(6):893-902. PubMed ID: 17295426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A generic method to detect electrophilic intermediates using isotopic pattern triggered data-dependent high-resolution accurate mass spectrometry.
    Lim HK; Chen J; Cook K; Sensenhauser C; Silva J; Evans DC
    Rapid Commun Mass Spectrom; 2008 Apr; 22(8):1295-311. PubMed ID: 18383206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of flavonoids using liquid chromatography with electrospray ionization and ion trap tandem mass spectrometry with an MS/MS library.
    Lee JS; Kim DH; Liu KH; Oh TK; Lee CH
    Rapid Commun Mass Spectrom; 2005; 19(23):3539-48. PubMed ID: 16261653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput approaches towards the definitive identification of pharmaceutical drug metabolites. 2. An example of how unexpected dissociation behaviour could preclude correct assignment of sites of metabolism.
    Holman SW; Wright P; Langley GJ
    Rapid Commun Mass Spectrom; 2009 Jul; 23(13):2017-25. PubMed ID: 19489039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid discovery and global characterization of chemical constituents and rats metabolites of Phellodendri amurensis cortex by ultra-performance liquid chromatography-electrospray ionization/quadrupole-time-of-flight mass spectrometry coupled with pattern recognition approach.
    Wang H; Yan G; Zhang A; Li Y; Wang Y; Sun H; Wu X; Wang X
    Analyst; 2013 Jun; 138(11):3303-12. PubMed ID: 23608925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategy for structural elucidation of drugs and drug metabolites using (MS)n fragmentation in an electrospray ion trap.
    Tozuka Z; Kaneko H; Shiraga T; Mitani Y; Beppu M; Terashita S; Kawamura A; Kagayama A
    J Mass Spectrom; 2003 Aug; 38(8):793-808. PubMed ID: 12938100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new approach to aid the characterisation and identification of metabolites of a model drug; partial isotope enrichment combined with novel formula elucidation software.
    Hobby K; Gallagher RT; Caldwell P; Wilson ID
    Rapid Commun Mass Spectrom; 2009 Jan; 23(2):219-27. PubMed ID: 19089848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of knowledge-based metabolic predictions with liquid chromatography data-dependent tandem mass spectrometry for drug metabolism studies: application to studies on the biotransformation of indinavir.
    Anari MR; Sanchez RI; Bakhtiar R; Franklin RB; Baillie TA
    Anal Chem; 2004 Feb; 76(3):823-32. PubMed ID: 14750881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of mass spectrometry for metabolite identification.
    Ma S; Chowdhury SK; Alton KB
    Curr Drug Metab; 2006 Jun; 7(5):503-23. PubMed ID: 16787159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatography-tandem mass spectrometry in the identification and determination of phase I and phase II drug metabolites.
    Holcapek M; Kolárová L; Nobilis M
    Anal Bioanal Chem; 2008 May; 391(1):59-78. PubMed ID: 18345532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of liquid chromatography/tandem mass spectrometry and chip-based infusion for improved screening and characterization of drug metabolites.
    Staack RF; Varesio E; Hopfgartner G
    Rapid Commun Mass Spectrom; 2005; 19(5):618-26. PubMed ID: 15685686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cysteinylation of pharmaceutical-grade human serum albumin by electrospray ionization mass spectrometry and low-energy collision-induced dissociation tandem mass spectrometry.
    Kleinova M; Belgacem O; Pock K; Rizzi A; Buchacher A; Allmaier G
    Rapid Commun Mass Spectrom; 2005; 19(20):2965-73. PubMed ID: 16178042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.